Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Axsome Therapeutics (AXSM) Tax Provisions (2023 - 2025)

Axsome Therapeutics (AXSM) has disclosed Tax Provisions for 3 consecutive years, with $500000.0 as the latest value for Q4 2025.

  • Quarterly Tax Provisions rose 488.24% to $500000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$500000.0 through Dec 2025, down 688.24% year-over-year, with the annual reading at -$500000.0 for FY2025, 688.24% down from the prior year.
  • Tax Provisions hit $500000.0 in Q4 2025 for Axsome Therapeutics, up from -$1.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $2.6 million in Q1 2023 to a low of -$1.0 million in Q2 2025.
  • Historically, Tax Provisions has averaged $80000.0 across 3 years, with a median of -$325000.0 in 2023.
  • Biggest five-year swings in Tax Provisions: skyrocketed 126.15% in 2024 and later surged 488.24% in 2025.
  • Year by year, Tax Provisions stood at -$325000.0 in 2023, then surged by 126.15% to $85000.0 in 2024, then soared by 488.24% to $500000.0 in 2025.
  • Business Quant data shows Tax Provisions for AXSM at $500000.0 in Q4 2025, -$1.0 million in Q2 2025, and $85000.0 in Q4 2024.